Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection.
about
Genetic susceptibility to distinct bladder cancer subphenotypesEvolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.Hepatitis C virus adaptation to T-cell immune pressureInfluence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccinesDendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Escape from HLA-B*08-Restricted CD8 T Cells by Hepatitis C Virus Is Associated with Fitness CostsLoss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27–restricted human immune responseMutational escape of CD8+ T cell epitopes: implications for prevention and therapy of persistent hepatitis virus infectionsMHC signaling during social communicationStatistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen designDoes genetic diversity predict health in humans?Effect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responsesAssociation between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory studySpecific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremiaHepatitis C virus infection in the human immunodeficiency virus infected patient.Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected womenHost genetic determinants of spontaneous hepatitis C clearance.Role of host genetic factors in the outcome of hepatitis C virus infection.Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infectionHLA-B alleles B*15:01 and B*15:02: opposite association with hepatitis C virus infection in Chinese voluntary blood donors.Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitopeHuman leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.Molecular and contextual markers of hepatitis C virus and drug abuse.Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.A sequence-based approach demonstrates that balancing selection in classical human leukocyte antigen (HLA) loci is asymmetric.Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed.The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population.HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.HLA and infectious diseases.Host genetics in immune-mediated hepatitis C virus clearance.Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections.Characterization of bovine MHC class II DRB3 diversity in South American Holstein cattle populations.Host genetics play a critical role in controlling CD8 T cell function and lethal immunopathology during chronic viral infection.HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.Association between BoLA-DRB3 and somatic cell count in Holstein cattle from Argentina.HLA DRB1 alleles and hepatitis C virus infection in chronic kidney disease patients.HLA class II alleles and chronic hepatitis C virus infection.
P2860
Q24624419-520DA37F-8676-4B31-A7DA-E847471B71F6Q26800980-B1E98488-B478-40E2-B9F5-B2200E5A8726Q26862729-E5FC7ED3-F7E2-43E4-8023-5FDE56FF63FAQ26999264-EB50DE88-A6A7-4AC7-8A20-3ACC2D6A9069Q27010312-2F85462A-A9D9-4A11-B5D9-CFDD539B5C08Q27487340-1094E2FD-B3C5-470A-9C24-4D3CDBBCA97BQ27487784-55C0CDCC-1A2B-4F6F-8CD5-A4EB8B4381BEQ28086907-3F208D50-3024-40EB-92F5-1A9744F40E0EQ28834594-F1D128CA-90C3-4EF7-A95B-70587381C3B8Q30361685-C78EAB77-DFE2-4BD5-9B56-F4DD3237F551Q33487165-71780E3C-7A74-4DB3-AAC3-7BC29775EF49Q33625437-A3BF5486-E966-49E2-869C-E061439E8DC6Q33988636-9FB5061C-FC6C-4DF1-937C-DBC34DB5C20DQ34158520-0B6CCF6E-B7CE-42E7-9A71-60673CC30A5AQ34168504-E02ABA44-D181-47DA-86B3-018AF2A124B0Q34499385-EC939E57-42FA-4226-AF3B-79F60432B69FQ35000910-A70B2C36-CFBB-4A3A-B4C3-C890B15AA72BQ35011376-73E11B54-B1B8-423A-BA0D-103086107F41Q35259735-B808F274-27C1-4947-B50D-0837EE53A881Q35350883-F2DCBD18-0DAB-41F0-B159-105F21406FE8Q35374519-214978A8-3340-4D4C-B51D-F8D1410BD425Q35404598-CA390384-E5B6-4040-BCEE-7199EEE6D6D6Q35446259-64A1EE59-765F-4E14-B286-C223049EFFA9Q35660841-94F7DCC2-8B85-4680-9B85-70995D408141Q35665865-2F4B7128-561F-422D-AFA6-E7E6E7500367Q35673342-001DF4A5-6E9B-4198-943F-9B7B751993FFQ36477643-14C269D8-97F8-4CCB-9D6A-6E7C1B067CE8Q36970735-57DE6EF1-0CD2-465E-8457-76D1BC9EA27FQ37166509-2435A6BD-75D3-460D-B322-A650E29B72D2Q37402195-E5061304-C8AA-410C-AEA0-9434E721E457Q37444410-D5674212-553F-488A-875F-0829DF71493DQ37862746-87B713CE-01FA-40B1-9416-08ECA2AB6D95Q38010203-BBA11DD5-615F-40C8-A3B4-A50AF833E0E0Q38088855-CF4DF2B7-E90E-4D6C-893E-291278EB708EQ39506439-DE23F80C-588B-47B4-9A94-C0FF9653F25CQ40120016-8125F2CE-CB2A-4BBE-A454-57777E50DABCQ44066657-EB961625-E424-4097-AE79-91B14A0492C9Q45001824-AE4AE4CB-0EE1-48AF-BE8F-C236EB0034C7Q45352716-C73D4532-6F8E-4507-AB17-470C59609655Q45366916-E025935A-2736-4AE5-B71A-83D252B815E7
P2860
Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Evidence for human leukocyte a ...... t hepatitis C virus infection.
@ast
Evidence for human leukocyte a ...... t hepatitis C virus infection.
@en
Evidence for human leukocyte a ...... t hepatitis C virus infection.
@nl
type
label
Evidence for human leukocyte a ...... t hepatitis C virus infection.
@ast
Evidence for human leukocyte a ...... t hepatitis C virus infection.
@en
Evidence for human leukocyte a ...... t hepatitis C virus infection.
@nl
prefLabel
Evidence for human leukocyte a ...... t hepatitis C virus infection.
@ast
Evidence for human leukocyte a ...... t hepatitis C virus infection.
@en
Evidence for human leukocyte a ...... t hepatitis C virus infection.
@nl
P2860
P356
P1433
P1476
Evidence for human leukocyte a ...... t hepatitis C virus infection.
@en
P2093
Carla Kuiken
Karina Yusim
P2860
P304
P356
10.1002/HEP.21889
P407
P577
2007-12-01T00:00:00Z